INNOVATION THAT MATTERS

Inside Perspectives: Will Immunotherapy Knock Out Cancer?

The answer is yes, and no. Advances in just the past five years have proven immunotherapy can stimulate the immune system’s natural capabilities to kill cancer cells, and possibly lead to cures...

Inside Perspectives on Cancer Immunotherapy: An Interview with MPM’s Christiana Bardon

Boston-based MPM Capital’s Christiana Bardon, M.D., describes immunotherapy as an exciting, transformative field in cancer treatment. She foresees dramatic improvements for patients over the next 10 years. “We’ve just turned the corner...

Inside Perspectives on Cancer Immunotherapy: An Interview with Kineta’s Shawn Iadonato

Shawn Iadonato and his team at Kineta are hoping to play a big role in the next frontier of immuno-oncology by making cold tumors hot and by closing the big gap...

Inside Perspectives on Cancer Immunotherapy: An Interview with Juno CEO Hans Bishop

Juno Therapeutics President and CEO Hans Bishop leads one of the most dynamic, pioneering companies in the field of cancer immunotherapy. He describes this exciting, new strategy for destroying cancer cells...

Inside Perspectives on Cancer Immunotherapy: An Interview with TCR2 Therapeutics CEO Garry Menzel

TCR2 Therapeutics CEO Garry Menzel, Ph.D., says immunotherapies represent “a new golden age” of medicines to treat cancer and much of the excitement surrounds their potential to cure patients, but he...

Inside Perspectives on Immunotherapy: An Interview with Advaxis CEO Daniel O’Connor

Advaxis Immunotherapies, led by President and CEO Daniel O’Connor, is developing a promising and versatile approach to immuno-oncology with its Listeria monocytogenes (Lm) antigen delivery system. Lm Technology™ shows the immune...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

INNOVATION THAT MATTERS

Inside Perspectives: Gene Editing Takes Center Stage

Depending on the scientific expert, gene editing is just another sophisticated gene therapy tool in the fight against human diseases or a technological advance...